FDA Adverse Event Injury Summary report: N

GUIDE CATHETER

MDR report key: 12573825 · Received October 4, 2021

Report

Report Number
3008264254-2021-00039
Event Type
Injury
Date Received
October 4, 2021
Date of Event
August 1, 2018
Report Date
September 10, 2021
Manufacturer
MEDOS INTERNATIONAL SARL
Product Code
DQY
PMA / PMN Number
K000715
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

(B)(4) UNDER MRN 3008264254-2021-00039 IS BEING RETRACTED. THE REPORT WAS SUBMITTED IN ERROR. RETRACTION OF INITIAL REPORT (B)(4) UNDER MRN 3008264254-2021-00039.

Additional Manufacturer Narrative · 0

(B)(4). LITERATURE ARTICLE CITATION: "COMPARISON OF MICRO-CLAMPING STENT-RETRIEVER THROMBECTOMY WITH CONVENTIONAL STENT-RETRIEVER THROMBECTOMY IN INTRACRANIAL LARGE VESSEL EMBOLISM" REVIEWED. LIU, Z. S., DENG, G., ZHOU, L. J., SUN, Y., ZHANG, X. J., KUANG, X. W., QIN, Y. L., WANG, J. X., & SHAN, Q. (2018). WORLD NEUROSURGERY , 116 , E662¿E669. HTTPS://DOI.ORG/10.1016/J.WNEU.2018.05.066 DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE THE LOT NUMBER WAS PROVIDED BY THE CUSTOMER. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

LITERATURE ARTICLE "COMPARISON OF MICRO-CLAMPING STENT-RETRIEVER THROMBECTOMY WITH CONVENTIONAL STENT-RETRIEVER THROMBECTOMY IN INTRACRANIAL LARGE VESSEL EMBOLISM" REVIEWED. LIU, Z. S., DENG, G., ZHOU, L. J., SUN, Y., ZHANG, X. J., KUANG, X. W., QIN, Y. L., WANG, J. X., & SHAN, Q. (2018). WORLD NEUROSURGERY , 116 , E662¿E669. HTTPS://DOI.ORG/10.1016/J.WNEU.2018.05.066 OBJECTIVE AND METHODS: TO EVALUATE THE EFFECTIVENESS OF MICROCLAMPING STENT-RETRIEVER THROMBECTOMY (MSRT) IN PATIENTS WITH ACUTE ISCHEMIC STROKE WITH INTRACRANIAL LARGE VESSEL EMBOLISM (ILVE), AND COMPARE IT WITH THAT OF CONVENTIONAL STENT-RETRIEVER THROMBECTOMY (CSRT). WE RETROSPECTIVELY EVALUATED 108 PATIENTS WITH ILVA TREATED BY MSRT (N [ 52) OR CSRT (N [ 56) FROM THE 2 PARTICIPATING INSTITUTIONS BETWEEN JANUARY 2016 AND NOVEMBER 2017. THE RATES OF SUCCESSFUL (MODIFIED THROMBOLYSIS IN CEREBRAL INFARCTION [MTICI] GRADE 2B OR 3) AND COMPLETE REPERFUSION (MTICI GRADE 3), TIME FROM GUIDE CATHETER PLACEMENT TO REPERFUSION, RATES OF FIRST-PASS SUCCESS, AND THE NUMBER OF PASSES FOR REPERFUSION WERE COMPARED BETWEEN THE MSRT AND CSRT GROUPS. LOT, MODEL AND CATALOG NUMBER ARE NOT AVAILABLE, BUT THE SUSPECTED CERENOVUS DEVICE POSSIBLY ASSOCIATED WITH REPORTED ADVERSE EVENTS: ENVOY CATHETER OTHER CERENOVUS DEVICES THAT WERE ALSO USED IN THIS STUDY: N/A. NON-CERENOVUS DEVICES THAT WERE ALSO USED IN THIS STUDY: N/A. ADVERSE EVENT(S) AND PROVIDED INTERVENTIONS: 11 PATIENTS EXPERIENCED SUBARACHNOID HEMORRHAGE POST-OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1471482 GUIDE CATHETER PERCUTANEOUS CATHETER DQY MEDOS INTERNATIONAL SARL

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening